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Abstract
Objective: To identify the microorganisms isolated on the pericatheter skin, catheter tip and blood stream of 
patients on hemodialysis by central venous catheter, to verify the profile of sensitivity of these microorganisms 
to antimicrobials and to assess the clinical evolution and mortality related to these microorganisms.
Methods: A cross sectional study. The strains were isolated from the patients on hemodialysis by central 
venous catheter that, in a previous study, presented pericatheter skin, catheter tip and blood stream infection 
and were analyzed for microbiological profile and lethality related.
Results: 128 microorganisms were isolated in the bloodstream in the 94 patients studied. There were 35 
cases of septicemia and 27 of endocarditis. The mortality in cases of endocarditis due to methicillin-resistant 
Staphylococcus aureus was 100%.
Conclusion: Infection in the bloodstream and endocarditis caused by methicillin-resistant Staphylococcus 
aureus was predictive of mortality and lethality.
Resumo
Objetivo: Identificar os microrganismos isolados da pele pericateter, ponta do cateter e corrente sanguínea de 
pacientes em hemodiálise por cateter venoso central, verificar o perfil de sensibilidade destes microrganismos 
aos antimicrobianos e avaliar a evolução clínica e a mortalidade relacionada a estes microrganismos.
Métodos: Estudo transversal. As cepas isoladas de pacientes em hemodiálise por cateter venoso central que 
em estudo prévio apresentaram infecção na pele pericateter, ponta do cateter e corrente sanguínea foram 
analisadas quanto ao perfil microbiológico e letalidade relacionada.
Resultados: Foram isolados 128 microrganismos em corrente sanguínea nos 94 pacientes estudados. 
Ocorreram 35 casos de septicemia e 27 de endocardite. A letalidade nos casos de endocardite por 
Staphylococcus aureus resistente à meticilina foi 100%.
Conclusão: Infecção em corrente sanguínea e endocardite por Staphylococcus aureus resistente à meticilina 
são preditivas de alta mortalidade e letalidade. 
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Introduction
Infection is a frequent cause of rehospitalization 
and the second leading cause of death in chronic 
renal patients on hemodialysis. The central venous 
catheter is largely responsible in the majority of cas-
es.(1) Studies have focused primarily on the patient’s 
skin around the insertion site, followed by the the 
colonization of the catheter insertion site, coloniza-
tion of the catheter by hematogenous dissemination 
from elsewhere and/or contamination of the infu-
sion liquid. In addition, dialysis patients are known 
to suffer from weakened defense mechanisms, at-
tributed in large proportions to the elevated comor-
bidity of diabetes mellitus and malignancies, as well 
as malnutrition particularly associated with uremia 
and hemodialysis treatment.(2)
Among the microorganisms, bacteria contribute 
to approximately 95% of infections, with a consid-
erable percentage of bacterial isolates resistant to 
antimicrobials. Antimicrobial resistance is a global 
and growing concern. The transfer of resistant mi-
croorganisms among patients, possibly, occurs via 
the hands and/or the respiratory tract of the health 
professionals, which can be contaminated at the 
time of contact with the patient and surfaces.(3)
From the epidemiological point of view, the 
Gram-positive cocci have emerged as key players, 
especially Staphylococcus aureus, coagulase-negative 
staphylococci and enterococci.(3,4,5) Although coag-
ulase-negative staphylococci are frequently isolated 
in blood cultures, they are clinically significant in 
less than 15.0% of cases. By being part of the skin 
microbia and submitting a relatively low virulence, 
they are usually considered contaminants of blood 
cultures. Although the bacteremia by Gram-nega-
tive rods have become less frequent, the associated 
mortality is higher when compared to Gram-posi-
tive cocci.(4)
The prevalence of methicillin-resistant Staphylococ-
cus aureus (MRSA) has increased dramatically, becom-
ing responsible for more than half of staphylococcal 
infections in various healthcare services worldwide. 
According to the Centers for Disease Control and Pre-
vention, it is estimated that approximately 25-30% of 
the population is a carrier of the bacteria.(6)
At the end of 1986, in Europe, and 1988, in 
the United States, clinically significant resistance to 
vancomycin was identified among the enterococci. 
At this time, infections caused by coagulase-nega-
tive Staphylococcus with reduced susceptibility to 
vancomycin have also been described.(7)
The emergence of resistance among the S. au-
reus to the glycopeptides became a constant concern 
among researchers. The transfer of the vanA gene 
of the enterococci for S. aureus at the experimen-
tal level suggested the potential of staphylococci 
to acquire these genes in vivo, producing clinical 
resistance.(7) Data from the Canadian Nosocomial 
Infection Surveillance Program showed that for ev-
ery thousand hospitalizations in 2007, there were 
8.62 new patients infected by MRSA and 1.32 new 
patients with S. aureus resistant to vancomycin per 
1000 admissions.(8)
As a function of high morbidity and mortality 
related to the infectious complications in hemo-
dialysis patients, we were motivated to conduct 
this study, which had as its objectives: to identify 
the primary microorganisms isolated on the peri-
catheter skin, at the tip of the catheter, and in the 
bloodstream of patients undergoing hemodialysis 
treatment by central venous catheter; to trace the 
profile of sensitivity of these microorganisms to 
antimicrobials; and, to assess the clinical evolution 
and case fatality related to these microorganisms in 
these patients.
Methods
This was a cross-sectional study conducted in the 
University Hospital of the Federal University of São 
Paulo, in the southeastern region of Brazil, in the 
period of January to April of 2013.
Records from 156 patient charts in hemodialy-
sis who used central venous catheters as the access 
route were studied, document analysis was made of 
the isolated microorganisms, of the variables relat-
ed to the length of time for catheter permanence, 
and infectious complications of 94 patients who 
developed infections in the bloodstream, the peri-
catheter skin or catheter tip. The catheter removal 
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occurred in the following situations: malfunction-
ing of the catheter, presence of local erythema and/
or purulent secretion or bacteremia without other 
identifiable source of infection as recommended by 
National Kidney Foundation Kidney Disease Out-
comes Quality Initiative (NKF KDOQI).(9)
The pericatheter skin samples were obtained us-
ing a swab - pre-moistened cotton swab - in a solu-
tion of calcium alginate (Diagnostic Cefar-Farmaco, 
São Paulo, Brazil), and were transported to the mi-
crobiology laboratory, where they were immediately 
rolled onto plates containing tryptic soy agar with 
5% sheep’s blood and agar of mannitol-salt (Difco 
Laboratories, Detroit, MI). All cultures were incu-
bated at a temperature of 35° C for 48 hours, and 
examined daily to search for evidence of growth.
The blood samples (20 ml) of the patients 
were collected in Batec vials and the cultures were 
processed by means of an automated method for 
isolating microorganisms (Bactec 9240, Becton 
Dickinson).
After removing the catheter, approximately 50 
mm from its tip was rolled across the plates of Ro-
dac that contained tryptic soy agar with 5% sheep’s 
blood (COMO, Oxoid, Basingstoke Hampshire, 
United Kingdom), and mannitol salt agar (ASM, 
Oxoid), which were previously prepared in the lab-
oratory according to the semi-quantitative method. 
Catheters that presented more than 15 colony form-
ing units were considered significantly colonized.
The disk diffusion method was employed to de-
termine the susceptibility profile, where the culture 
plates of blood agar were selected for three to five 
isolated and pure colonies, and further, transferred 
to a tube containing 5 ml of saline solution. The 
bacterial suspension had a measured turbidity in the 
digital turbidimeter (Baxter, Sacramento, USA) and 
the scale used was a that of 0.5 McFarland, which 
corresponds to a bacterial concentration of about 1 
to 2 x 108 CFU/ml. The sowing was carried out on 
a Müller-Hinton agar board, as recommended by 
CLSI M100-S20.(10)
The plates containing the discs impregnated 
with the clavulanic acid, and antibiotics (amika-
cin, cefepime, cefoxitin, ceftazidime, ciprofloxacin, 
clindamycin, erythromycin, gentamicin, imipen-
em, meropenen, netilmicin, nitrofurantoin, nor-
floxacin, oxycillin, teicoplanin, tobramycin, and 
vancomycin) were placed in an oven at ± 35 º C for 
24 hours for further reading of the halos. The in-
terpretation of the results was performed according 
to the criteria established by the CLSI M100-S20. 
Staphylococcus aureus ATCC 25923 E. faecalis 
ATCC 29212, and Klebsiella pneumoniae carbap-
enemase-producing ATCC BAA-1705 strains were 
used as controls.(10)
A descriptive analysis was performed, and pre-
sented in absolute numbers and percentages. We 
calculated the odds ratios and confidence intervals 
(95% CIs). The statistical program used was the 
Statistical Package for the Social Sciences (SPSS), 
version 14.0.
The study followed the development of national 
and international standards of ethics in research in-
volving human beings.
Results
In table 1, the 240 microorganisms are presented 
that were isolated in the cultures of 94 patients in 
hemodialysis through the central venous catheter 
that presented blood stream infection. 
The gram-positive microorganisms were pre-
dominant and among these the S. aureus (76%) were 
Table 1. Isolated microorganisms
Microorganisms
Skin
n(%)
Tip
n(%)
Blood
n(%)
Gram – positive cocci (119) 522(41) 35(60) 62(49)
Shaphylococcus aureus (91) 311(51) 27(77) 53(85)
Shaplylococcus coagulase – negativo (18) 8(31) 5(14) 5(7)
Enterococcus (10) 2(18) 3(8) 5(8)
Gram – negative cocci (91) 115(28) 18(32) 58(45)
Pseudomonas aeruginosa (38) 106(40) 7(39) 25(43)
Acinetobacter baumanii (32) 4(27) 7(39) 21(35)
Enterobacter (12) 2(13) 2(11) 8(14)
Klebsiella pneumoniae (07) 3(20) 2(11) 4(8)
Fungus (30) 117(31) 5(8) 8(6)
Cândida spp (22) 13(76) 4(80) 5(62)
Others (08) 4(24) 1(20) 3(38)
Legend: Skin – n=54; Tip – n=58; Blood – n=128
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isolated more frequently in the three sampling sites, 
with 51% of the isolates in the skin at the cathe-
ter insertion site, 77% of the isolates at the catheter 
tips, and 85% of isolates in the blood. Among the 
Gram-negative microorganisms, Pseudomonas aeru-
ginosa (40%), and Acinetobacter baumannii (34%) 
were prevalent, being the most frequently isolated 
in the blood (43% -34%) in the catheter tip (39% 
-39%) and in the skin at the catheter insertion site 
(40% -27%), respectively.
The fungi were less prevalent (13%), and Can-
dida spp appeared in 73% of these. Unlike the 
gram-positive and gram-negative bacteria, fungi 
were isolated more frequently in the skin at the 
catheter insertion site (31%), followed by the cath-
eter tip (8%) and less frequently in the blood (6%).
Table 2 shows the analysis of the profile of sen-
sibility of the isolated microorganisms with higher 
frequency in the blood cultures and the permanence 
of the central venous catheter.
We observed an elevated resistance higher 
than 70%, of the micro-organisms to the 11 an-
tibiotics tested, and the S. aureus was only 100% 
sensitive to teicoplanin and vancomycin. Among 
the non-fermenting gram-negative bacilli, P. 
aeruginosa was 100% sensitive only to clavulanic 
acid and tazobactam, and the A. Baumanii pre-
sented a highly resistant profile, 80% sensitive 
only to imipenem.
We found that in the catheters implanted and 
maintained for a period exceeding 21 days, there 
were significant increases in the number of microor-
ganisms, and also an increase of resistant strains of 
virtually all organisms, and that the resistant strains 
were 80% more isolated with the increased central 
venous catheter permanence.
After 21 days of implantation of central ve-
nous catheter, the risk of isolating strains of S. 
aureus was 50% higher compared to other micro-
organisms, with strains of Staphylococcus aureus 
resistant to methicillin being two times more iso-
lated than MSSA strains (Odds: 2.04, CI: 0.54 to 
7.70). Resistant strains of Pseudomonas aerugino-
sa were isolated four times more (odds: 4.00, CI: 
0.37 to 42.3) than the sensitive strains, and resis-
tant strains of Acinetobacter baumannii were three 
times more isolated than the susceptible strains 
(odds: 2.75, CI: 0.28 to 26.60).
In table 3 we present the clinical evolution of 
patients and the related lethality to the profile of the 
microorganisms isolated in the blood stream.
Of the 94 patients previously studied, 62 (66%) 
developed severe infectious complications, 35 
(56%) sepsis, and 27 (44%) endocarditis. Of the 
patients with endocarditis, 15 (56%) died.
Seventeen strains were isolated from blood cul-
tures of the 12 patients who developed septicemia 
and died. It was found that strains of Staphylococ-
cus aureus were the most prevalent, among which 
36.5% were due to strains with 70% resistance to 
five or more of the 11 antibiotics tested. The risk 
of death was 50% higher in patients with resistant 
strains, four times greater (odds: 4.3, CI: 0.80 to 
22.90) in patients with septicemia who presented 
strains of Staphylococcus aureus resistant to methicil-
lin, compared to other microorganisms.
Sixteen strains were isolated from the blood cul-
tures of the 15 patients who developed endocarditis 
and died. The Staphylococcus aureus were the most 
prevalent, among which 60% were of strains with 
70% of resistance to five or more antibiotics of the 
11 tested. The lethality observed the group of pa-
tients with endocarditis due to MRSA was 100% 
(odds: 11.0; IC :1,16-103, 94). We emphasize that 
52% of the patients with a confirmed diagnosis of 
Table 2. Profile of the sensiblity of the microorganisms and 
permanence of the central venous catheter
Microorganisms TC>21days*n(%)
TC=<21days**
n(%)
Odds Ratio 
(IC 95%)
Gram-positive 
S.aureus
MRSA 
MSSA
Gram – negative
Pseudomonas 
aeruginosa
Resistant
Sensitive
Acinetobacter 
baumanii
Resistant
Sensitive
40(52)
19(48)
21(52)
20(26)
10(50)
10(50)
17(22)
11(47)
6(53)
13(59)
4(31)
9(69)
5(23)
1(20)
4(80)
4(18)
2(33)
2(67)
2.04 
(0.54-7.70)
4.00 
(0.37-42.37)
2.75 
(0.28-26.60)
Legend: TC – Time of catheter; *TC>21days – n=77; ** TC=<21days – n=22
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endocarditis presented concomitantly the same mi-
croorganism isolated from the blood and the cath-
eter tip.
Discussion
The occurrence of infections caused by resistent mi-
croorganisms constitutes a worldwide public health 
problem. Resistent bacterias, such as Acinetobacter 
baumannii, Staphylococcus aureus, Pseudomonas 
aeruginosa, Klebsiella pneumoniae and Enterococcus 
spp, have become increasingly common in health 
care institutions.(4)
The infections caused by gram-positive patho-
gens are still shown to be predominant, character-
ized by a reduced sensitivity profile to different anti-
microbials, which contributes to reducing the ther-
apeutic options and the high rates of mortality.(11)
The high rates of catheter-related blood stream 
infection (CRBSI) associated with the increased 
growth in the rates of resistence have made these in-
fections particularly worrisome. Various conditions 
have been identified as risk factors for the develop-
ment of CRBSI, such as the duration of catheter 
placement, skin colonization at the catheter inser-
tion site, and the frequent manipulation of the ve-
nous line.(1)
The skin is the principal source for colonization 
and infection of the short-dwelling catheter. The 
bacteria that are in the skin of the patient migrate 
along the surface, colonizing the distal end, result-
ing in infection. However, these micro-organisms 
Table 3. Clinical evolution and lethality related to the profile of microorganisms isloated in the blood stream
Microrganisms
Septicemia
n(%)
Death*
n(%)
Odds
(IC 95%
Endocarditis
n(%)
Death**
n(%)
Odds
(IC 95%)
MRSA 7(13) 5(28) 4.3
(0.80-22.90)
9(27) 9(45) 11.0
(1.16-103.94)
MSSA 18(33) 3(17) 11(33) 1(5)
P. aeruginosa MR 8(18) 3(17) 2.3
(0.18-27.37)
3(15) 2(15%) 1.3 
(0.06-26.61)
P. aeruginosa S/I 6(11) 1(6) 2(3) 1(5)
A. baumanii MR 6(13) 4(28) 2.0
(0.14-26.73)
2(12) 2(15%) 2.0 
(0.10-44.35)
A. baumanii S/I 3(6) 1(6) 2(3) 1(5)
Legend: Septicemia – n=35; *Death – n=12; Endocarditis – n=27; **Death – n=15
can also colonize the inner surface of the catheter, 
where they adhere and can become incorporated 
into a biofilm which enables the sustenance of the 
local infection and hematogenous dissemination. 
When catheters are used for long periods, intralu-
minal colonization is greater than extraluminal.(2)
The contamination of the connection was the 
possible origin of colonization in long-term indwell-
ing catheters (greater than 30 days), responsible for 
infection related to the central venous catheter, 
while pericatheter skin contamination determined 
the beginning of colonization of the short-term 
catheter (less than 10 days).(12) Given these results, 
researchers concluded that the permanence of the 
central venous catheter is considered a major cause 
of infection.(1,2,12) In the USA about five million 
central venous catheters are introduced annually. In 
this context, data from the CDC indicate blood-
stream infection rates related to the catheters of 5.3 
per 1000 catheter-days, with a rate of colonization 
in 50% of cases.(13)
In the present study we found that in the cath-
eters implanted and maintained for a period ex-
ceeding 21 days, there were significant increases in 
the number of microorganisms isolated, with an 
increase in resistant strains of virtually all microor-
ganisms. After 21 days of implantation of the cen-
tral venous catheter, the risk of isolating strains of S. 
aureus increased by two times, methicillin resistant 
Staphylococcus aureus was isolated five times more 
in catheters with a permanence time greater than 
21 days. The risk of isolating strains of Pseudomo-
nas aeruginosa and Acinetobacter baumannii after 21 
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days of implantation of the central venous catheter 
doubled, and the multiresistant strains were 90% 
more isolated with increasing permanence of cen-
tral venous catheters.
The discovery of the antimicrobials revolu-
tionized the treatment of infections, but their in-
discriminate use has led to the rapid emergence 
of bacterial resistance, which shows increasing 
prevalence in healthcare facilities.(3)  Currently, 
in the USA, 55% of infections caused by Staph-
ylococcus aureus are related to MRSA. In France, 
isolation of resistant bacteria ranges from 30% 
to 40%, reaching a percentage of up to 78% of 
the units.(14)
According to SENTRY (the Program of Anti-
microbial Surveillance) results from Latin Amer-
ica and Brazil, the non-fermenting Gram neg-
ative rods (Acinetobacter spp. and Pseudomonas 
aeruginosa) multidrug-resistance, and the En-
terobacteriaceae (Escherichia coli, Salmonella spp, 
Shigella spp and Proteus mirabilis), producers of 
the extended spectrum beta-lactamase (ESBL) 
constitute the main problem in pharmaceutical 
resistence in these countries. We observed high 
rates of resistant isolates, except the polymyxins, 
since the program’s inception, in 1997.(14) Of the 
Gram-positive cocci, oxycillin resistance among 
staphylococci represents an important problem 
in Latin America and the United States. Howev-
er, rates vary significantly between hospitals and 
countries, although the percentage of isolates 
of Staphylococcus aureus sensitive to oxacillin 
originatimg from cases of bacteremia in Brazil, 
in comparison to Latin America, has been ap-
proached: 68.2% and 68.5%, respectively.(14)
The prevalence of MRSA increased dramatical-
ly, becoming responsible for more than half of the 
staphylococcal infections in various healthcare ser-
vices worldwide. At the end of the 1980s, clinically 
significant resistance to vancomycin became iden-
tified among enterococci (VRE). At this time, in-
fections caused by coagulase-negative staphylococci 
(CNS), with reduced susceptibility to vancomycin 
have also been described. The emergence of resis-
tance among S. aureus to glycopeptides has become 
a constant concern among researchers. The transfer 
of the vanA enterococci gene for S. aureus at the 
experimental level suggested the potential of staph-
ylococci to acquire these genes in vivo, producing 
clinical resistance. In addition, laboratory studies 
with coagulase-negative Staphylococcus and S. aureus 
exposed to progressively higher levels of glycopep-
tides demonstrated the ability of these agents to se-
lect resistant subpopulations.(8)
In our study we observed an elevated resistance, 
greater than 70%, of the microorganisms to the antimi-
crobials tested, and S. aureus was only 100% sensitive 
to teicoplanin and vancomycin. Among the non-fer-
menting gram-negative bacilli, P.  aeruginosa was 100% 
sensitive only to the clavulanic acid and tazobactam 
and the A. Baumanii presented a highly resistant pro-
file, 80% sensitive only to the Imipenem.
Patients hospitalized with infecction by S. au-
reus have a five times higher risk of mortality.(13) 
Mortality associated with bacteremia, caused by S. 
aureus, varies from 11.9 to 46.5% per year.(15)
Although the protocols recommended by 
the Centers for Disease Control and Prevention 
(CDC) are adopted in our service, the blood 
stream infection (BSI) mortality and the lethal-
ity related to the use of central venous catheters 
for dialysis is elevated, as well as the prevalence 
of the resistant microorganisms. In this study, 
62 patients developed severe infectious compli-
cations, 37% with septicemia, 29% with endo-
carditis - 56% of these resulted in death. The 
risk of death was higher than 50% in patients 
with resistant strains, four times higher in pa-
tients with septicemia who presented strains of 
MRSA, compared to other microorganisms. The 
lethality rate was 100% in the group of patients 
with endocarditis due to MRSA.
This study is in line with the current litera-
ture, complementing the results of the previously 
published studies in this journal, reinforcing that 
S. aureus are responsible for most infections and 
that their control proposes a challenge. Since the 
possibility of the emergence of bacteria resistant to 
all available antimicrobials in clinical practice is a 
current reality, health professionals should be aware 
of precautions, including staff education on prop-
er techniques for insertion and maintenance of the 
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central venous catheter and instituting more effec-
tive and efficient quality control measures, aimed 
at reducing horizontal transmission of these patho-
gens in hospital environments.
Further studies are suggested that correlate 
cross-infection to be harnessed to analyze the 
colonization of patients with chronic renal fail-
ure before starting dialysis therapy, thereby en-
abling the evaluation of the issues involved in 
cross-transmission of microorganisms and the 
development of ICS, preventing the emergence 
of these pathogens, thus reducing the high le-
thality observed in these patients.
Conclusion
Among the main microorganisms isolated in 
cultures of hemodialysis patients by central ve-
nous catheter, the S. aureus were predominant 
in the three collection locations. We found that 
in the catheters implanted and maintained for 
a period exceeding 21 days, there were signifi-
cant increases in the number of microorganisms 
isolated, with an increase of resistant strains of 
virtually all microorganisms. We observed an el-
evated resistance exceeding 70%, of the micro-
organisms to the antibiotics tested. Patients who 
presented resistant strains had a 50% increased 
risk of death compared to the other microorgan-
isms. The observed mortality was 100% in the 
group of patients with endocarditis due to meth-
icillin-resistant Staphylococcus aureus (MRSA).
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